Malignant neoplasms following cardiac transplantation

Area of Science:

• Cardiology
• Oncology
• Transplantation Medicine

Background:

• Cardiac transplantation is a life-saving procedure.
• Immunosuppression post-transplantation increases cancer risk.
• Understanding cancer spectrum in cardiac recipients is crucial.

Purpose of the Study:

• To investigate the incidence and spectrum of malignant neoplasms in cardiac transplant recipients.
• To compare cancer development in cardiac recipients with renal homograft recipients.

Main Methods:

• Retrospective analysis of 124 cardiac transplant patients at Stanford University Medical Center (1968-1977).
• Follow-up periods ranged from 9.7 to 18.3 months.
• Documented development of malignant neoplasms and causes of death.

Main Results:

• Seven patients (5.6%) developed malignant neoplasms.
• Neoplasms included lymphoproliferative disorders, skin cancers, acute leukemia, and colon carcinoma.
• Visceral tumors contributed to 11% of post-transplant deaths within three months.

Conclusions:

• Cardiac transplant recipients exhibit a cancer incidence and spectrum comparable to renal homograft recipients.
• Malignant neoplasms, particularly visceral tumors, pose a significant mortality risk post-cardiac transplantation.